3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Kidney Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Cisplatin
1
Cerebral Decortication
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.